Conclusions The available evidence suggests that diabetes self-management education can reduce all-cause mortality risk in type 2 diabetes patients .
Background Diabetes self-management education is an essential part of diabetes care , but its impact on all-cause mortality risk of type 2 diabetes patients is unclear .
A systematic review and meta- analysis aim ing to eluci date the impact of diabetes self-management education on all-cause mortality risk of type 2 diabetes patients was performed .
Starting insulin in type 2 diabetes: continue oral hypoglycemic agents? A randomized trial in primary care.
OBJECTIVE To evaluate the effects of insulin 30/70 twice daily or bedtime isophane ( NPH ) insulin plus continued sulfonylurea and metformin in patients with type 2 diabetes in primary care . STUDY DESIGN Open-label , r and omized trial . POPULATION Persons younger than 76 years with type 2 diabetes whose disease had not been controlled with oral hypoglycemic agents alone . A total of 64 insulin-naive patients treated with maximal feasible dosages of sulfonylurea and metformin ( baseline glycosylated hemoglobin [HbA1c]=8.5 % ) were r and omly assigned to insulin monotherapy ( IM group ; n=31 ) or insulin in addition to unchanged oral hypoglycemic medication ( IC group ; n=33 ) for 12 months . Insulin doses were adjusted to obtain fasting glucose < 7.0 mmol/L and postpr and ial glucose < 10.0 mmol/L. OUTCOMES MEASURED Outcome measures included HbA1c , treatment failure , weight , hypoglycemic events and symptoms , satisfaction with treatment , general well-being , and fear of injecting insulin and testing . RESULTS HbA1c improved from 8.3 % to 7.6 % in the IC group , and from 8.8 % to 7.6 % in the IM group ( P = NS ) . The IC group had 24 % treatment failures , compared with 2 % in the IM group ( P=.09 ) . Patients in the IC group had less weight gain than those in the IM group ( 1.3 vs 4.2 kg ; P=.01 ) , and they reported fewer hypoglycemic events ( 2.7 vs 4.3 ; P=.02 ) . Increased satisfaction with treatment was equal in the 2 groups , and general well-being improved by 3.0 points more in the IC group ( P=.05 ) . Fear of self-injecting and self-testing did not differ . CONCLUSIONS Bedtime NPH insulin added to maximal therapy with sulfonylurea and metformin is an effective , simple , well-tolerated approach for patients with uncontrolled type 2 diabetes
Conclusions The available evidence suggests that diabetes self-management education can reduce all-cause mortality risk in type 2 diabetes patients .
Background Diabetes self-management education is an essential part of diabetes care , but its impact on all-cause mortality risk of type 2 diabetes patients is unclear .
A systematic review and meta- analysis aim ing to eluci date the impact of diabetes self-management education on all-cause mortality risk of type 2 diabetes patients was performed .